Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
Open-market buys, last 90 days
$82,244
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$82,244. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2012-06-22 Runge Jeffrey W. Director Grant or award · Stock option (right to buy) +20,000 20,000
2012-06-22 McCleary Joel Director Grant or award · Stock option (right to buy) +20,000 20,000
2012-06-22 MARKISON BRIAN A Director Grant or award · Stock option (right to buy) +20,000 20,000
2012-06-22 GILL JOHN Director Grant or award · Stock option (right to buy) +20,000 20,000
2012-03-07 RICHMAN ERIC I See Remarks Shares withheld for taxes −22,500 176,822

Page 43 of 43 · 845 trades